IART vs PRCT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IART · Integra Lifesciences$13.42 ▼ 4.96%
PRCT · PROCEPT BioRobotics$20.62 ▲ 1.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IART +10.2%
- PRCT -33.4%
Head to head
| Metric | IART | PRCT |
|---|---|---|
| Price | $13.42 | $20.62 |
| Change today | ▼ 4.96% | ▲ 1.73% |
| Market cap | $1.04B | $1.19B |
| Return, 3 months | -21.4% | -5.0% |
| Return, year to date | +8.1% | -34.5% |
| Return, 1 year | +11.5% | -35.4% |
| P/E (TTM) | 78.9 | – |
| P/B | 1.0 | 3.6 |
| P/E percentile vs own 5y | 99th | 88th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +2.3% | +19.3% |
| Net profit growth (YoY) | +374.8% | -37.2% |
| Gross margin | 52.4% | 64.2% |
| Operating margin | 4.4% | -33.9% |
| Net margin | 0.8% | -32.5% |
| Return on equity | 0.7% | -30.2% |
| Analyst target vs. price | +13.9% | +11.0% |
| Analyst buy share | 13% | 33% |
| RSI (14) | 48 | 57 |
| 30-day volatility | 94.4% | 66.3% |
| Max drawdown, 1 year | -44.1% | -54.8% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PRCT is the largest of the group by market value.
- IART has returned the most over the past year.
- PRCT is growing revenue fastest.
- IART keeps the most profit per dollar of sales.
- PRCT has been the calmest stock over the last 30 days.